Skip to main content
. 2020 Nov 5;15(11):e0241369. doi: 10.1371/journal.pone.0241369

Table 3. Vaccine-wise saving of doses.

Antigen Utilization of doses (in Million) Saving (%)
Pre-eVIN Post-eVIN
BCG 45.4 37.5 17.4
DPT 29.8 27.3 8.4
Hep-B 28.9 6.5 77.5
Measles 44.0 34.7 21.1
OPV 47.6 31.1 34.7
Pentavalent 45.5 35.1 22.9
TT 64.1 42.8 33.2
Total 305.3 215.0 29.6